CIK 0001729427 · Non-accelerated filer<br>Smaller reporting company
CNS Pharmaceuticals, Inc.
Sign in to watch- Ticker
- CNSP
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- NV
- Entity type
- operating
- EIN
- 822318545
- Phone
- 1-800-946-9185
- Business address
- 2100 WEST LOOP SOUTH, SUITE 900, HOUSTON, TX, 77027
- 4 Grant or award Chief Financial Officer acquired 33,000 shares (grant or award)
- 4 Grant or award Director acquired 11,100 shares (grant or award)
- 4 Grant or award Director acquired 3,750 shares (grant or award)
- 4 Grant or award Chief Executive Officer acquired 35,000 shares (grant or award)
- 8-K Event Results of operations
- 10-K Report Annual Report
- 8-K Event Delisting notice
- 424B3 Offering Prospectus
- EFFECT Other Notice of Effectiveness
- CORRESP Other Correspondence Between Filers and SEC Staff
- UPLOAD Other SEC-generated Letter
- 4 Other disposition 10% owner disposed of 1,495,867 shares (other)
- S-3 Offering Registration Statement
- 8-K Event Regulation FD disclosure
- 8-K Event Material agreement · Unregistered share sale · Other events
- 4 Open-market buy Chief Financial Officer bought 5,000 shares at $0.94 ($4,702)
- 8-K Event Regulation FD disclosure
- 4 Open-market buy Chief Financial Officer bought 4,500 shares at $1.15 ($5,192)
- 4 Grant or award Chief Executive Officer acquired 5,000 shares (grant or award)
- 10-Q Report Quarterly Report
Page 14 of 20 · 390 filings